Alpha 2.0
Login Register
» Articles » PMID: 29808445

Assessing Disparities in the Rates of HCV Diagnoses Within American Indian or Alaska Native Populations Served by the U.S. Indian Health Service, 2005-2015

Overview
Journal J Community Health
Publisher Springer
Specialty Public Health
Date 2018 May 30
PMID 29808445
Citations 2
Authors
Brigg Reilley
Jessica Leston
Mona Doshani
Dana L Haberling
Marissa Person
Thomas Weiser
Melissa Collier
Jonathan Iralu
Jorge Mera
Rick Haverkate
Affiliations
Soon will be listed here.
Abstract

Hepatitis C virus (HCV) disproportionately affects American Indians/Alaska Natives (AI/AN). The Indian Health Service (IHS), via federal and tribal health facilities provides medical services to an estimated 2.2 million AI/AN people in the United States. HCV diagnoses, defined by International Classification of Diseases 9th Revision, Clinical Modification (ICD-9-CM) codes, were analyzed from 2005 to 2015. Results showed 29,803 patients with an HCV diagnosis; 53.4% were among persons born 1945-1965 and overall HCV burden was higher among males than females. These data will help inform local, regional, and national efforts to address, plan for and carry out a national strategy to provide treatment for HCV infected patients and programs to prevent new HCV infections.

Citing Articles

Infectious diseases in Indigenous populations in North America: learning from the past to create a more equitable future.

Lee N, King A, Vigil D, Mullaney D, Sanderson P, Ametepee T Lancet Infect Dis. 2023; 23(10):e431-e444.

PMID: 37148904 PMC: 10156139. DOI: 10.1016/S1473-3099(23)00190-1.

Hepatitis C drug prescriptions and Medicaid policies--four states, Indian health care system, USA 2018.

Reilley B, Miller M, Hudson M, Haverkate R, Leston J Int J Equity Health. 2019; 18(1):190.

PMID: 31801547 PMC: 6894296. DOI: 10.1186/s12939-019-1101-4.

References
1.
van der Meer A, Veldt B, Feld J, Wedemeyer H, Dufour J, Lammert F . Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis. JAMA. 2012; 308(24):2584-93. DOI: 10.1001/jama.2012.144878. View
2.
Bruno S, Di Marco V, Iavarone M, Roffi L, Crosignani A, Calvaruso V . Survival of patients with HCV cirrhosis and sustained virologic response is similar to the general population. J Hepatol. 2016; 64(6):1217-23. DOI: 10.1016/j.jhep.2016.01.034. View
3.
Edlin B, Eckhardt B, Shu M, Holmberg S, Swan T . Toward a more accurate estimate of the prevalence of hepatitis C in the United States. Hepatology. 2015; 62(5):1353-63. PMC: 4751870. DOI: 10.1002/hep.27978. View
4.
Smith B, Morgan R, Beckett G, Falck-Ytter Y, Holtzman D, Teo C . Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965. MMWR Recomm Rep. 2012; 61(RR-4):1-32. View
5.
Ly K, Hughes E, Jiles R, Holmberg S . Rising Mortality Associated With Hepatitis C Virus in the United States, 2003-2013. Clin Infect Dis. 2016; 62(10):1287-1288. PMC: 11089523. DOI: 10.1093/cid/ciw111. View